title: Continuation of thiazolidinedione therapy in patients without left ventricular dysfunction who developed edema and congestive-heart-failure symptoms.
authors.affiliation: Veterans Affairs Medical Center, Bay Pines, FL, USA. fwang@harthosp.org
authors.forename: Fei
authors.initials: F
authors.lastname: Wang
authors.forename: Cunegundo
authors.initials: C
authors.lastname: Vergara
authors.forename: Jana
authors.initials: J
authors.lastname: Carabino
authors.forename: Alicia
authors.initials: A
authors.lastname: Desilets
authors.forename: Ryan
authors.initials: R
authors.lastname: Vasquez
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000139:chemically induced*; D005260:Female; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008024:Ligands; D008297:Male; D008875:Middle Aged; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D007004:Hypoglycemic Agents; D008024:Ligands; D045162:Thiazolidinediones; C089946:2,4-thiazolidinedione